Europe AI in Pathology Market Size, Share & Trends Analysis Report By Neural Network, By Application (Drug Discovery, Disease Diagnosis & Prognosis, Clinical Workflow, and Others), By End User, By Component, By Country and Growth Forecast, 2023 - 2030
The Europe AI in Pathology Market would witness market growth of 15.4% CAGR during the forecast period (2023-2030).
AI in pathology has accelerated the transition toward personalized medicine by enabling the identification of specific biomarkers associated with individual patient profiles. In order to identify unique biomarkers, machine learning algorithms can analyze diverse data sets, including genetic information, pathology images, and clinical records. This facilitates the development of targeted therapies, optimizing therapy plans based on an individual's genetic makeup and disease characteristics. The seamless integration of AI in pathology with electronic health records has streamlined data management and accessibility. This integration enhances the efficiency of healthcare systems by providing a comprehensive view of patient data and facilitating data-driven decision-making.
The integration of AI in pathology has synergized with telepathology, allowing pathologists to collaborate remotely for consultations and second opinions. AI algorithms can assist in rapidly analyzing pathology images, enabling timely and accurate diagnoses even in geographically dispersed locations. This trend has proven especially valuable in addressing healthcare disparities and improving access to pathology expertise in underserved regions. AI algorithms excel in image recognition and pattern detection, making them invaluable for diagnostic assistance in pathology.
Europe is working on establishing clear regulatory frameworks for the use of AI in healthcare. Well-defined guidelines promote AI technologies' responsible and ethical deployment, fostering confidence among healthcare providers and patients. Implementing telepathology, facilitated by AI, enables remote access to pathology services. Due to the aforementioned factors the market growth will drive in this region.
The Germany market dominated the Europe AI in Pathology Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,215.1 Thousands by 2030. The UK market is exhibiting a CAGR of 14.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 16.2% during (2023 - 2030).
Based on Neural Network, the market is segmented into Convolutional neural networks (CNNs), Generative adversarial networks (GANs), Recurrent neural networks (RNNs), and Others. Based on Application, the market is segmented into Drug Discovery, Disease Diagnosis & Prognosis, Clinical Workflow, and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Reference Laboratories, and Academic & Research Institutes. Based on Component, the market is segmented into Scanners, and Software. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Hologic, Inc., Visiopharm A/S, Paige AI, Inc., PathAI, Inc., Aiforia Technologies Plc, Indica Labs, Inc., Optrascan, Inc. (Optra Ventures, LLC), MindPeak GmbH.
Scope of the Study
Market Segments covered in the Report:
By Neural Network
- Convolutional neural networks (CNNs)
- Generative adversarial networks (GANs)
- Recurrent neural networks (RNNs)
- Others
- Drug Discovery
- Disease Diagnosis & Prognosis
- Clinical Workflow
- Others
- Pharmaceutical & Biotechnology Companies
- Hospitals & Reference Laboratories
- Academic & Research Institutes
- Scanners
- Software
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Koninklijke Philips N.V.
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Visiopharm A/S
- Paige AI, Inc.
- PathAI, Inc.
- Aiforia Technologies Plc
- Indica Labs, Inc.
- Optrascan, Inc. (Optra Ventures, LLC)
- MindPeak GmbH
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe AI in Pathology Market, by Neural Network
- 1.4.2 Europe AI in Pathology Market, by Application
- 1.4.3 Europe AI in Pathology Market, by End User
- 1.4.4 Europe AI in Pathology Market, by Component
- 1.4.5 Europe AI in Pathology Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- Chapter 4. Competition Analysis - Global
- 4.1 Market Share Analysis, 2022
- 4.2 Recent Strategies Deployed in AI in Pathology Market
- 4.3 Porter’s Five Forces Analysis
- Chapter 5. Europe AI in Pathology Market, By Neural Network
- 5.1 Europe Convolutional neural networks (CNNs) Market, By Country
- 5.2 Europe Generative adversarial networks (GANs) Market, By Country
- 5.3 Europe Recurrent neural networks (RNNs) Market, By Country
- 5.4 Europe Others Market, By Country
- Chapter 6. Europe AI in Pathology Market, By Application
- 6.1 Europe Drug Discovery Market, By Country
- 6.2 Europe Disease Diagnosis & Prognosis Market, By Country
- 6.3 Europe Clinical Workflow Market, By Country
- 6.4 Europe Others Market, By Country
- Chapter 7. Europe AI in Pathology Market, By End User
- 7.1 Europe Pharmaceutical & Biotechnology Companies Market, By Country
- 7.2 Europe Hospitals & Reference Laboratories Market, By Country
- 7.3 Europe Academic & Research Institutes Market, By Country
- Chapter 8. Europe AI in Pathology Market, By Component
- 8.1 Europe Scanners Market, By Country
- 8.2 Europe Software Market, By Country
- Chapter 9. Europe AI in Pathology Market, By Country
- 9.1 Germany AI in Pathology Market
- 9.1.1 Germany AI in Pathology Market, By Neural Network
- 9.1.2 Germany AI in Pathology Market, By Application
- 9.1.3 Germany AI in Pathology Market, By End User
- 9.1.4 Germany AI in Pathology Market, By Component
- 9.2 UK AI in Pathology Market
- 9.2.1 UK AI in Pathology Market, By Neural Network
- 9.2.2 UK AI in Pathology Market, By Application
- 9.2.3 UK AI in Pathology Market, By End User
- 9.2.4 UK AI in Pathology Market, By Component
- 9.3 France AI in Pathology Market
- 9.3.1 France AI in Pathology Market, By Neural Network
- 9.3.2 France AI in Pathology Market, By Application
- 9.3.3 France AI in Pathology Market, By End User
- 9.3.4 France AI in Pathology Market, By Component
- 9.4 Russia AI in Pathology Market
- 9.4.1 Russia AI in Pathology Market, By Neural Network
- 9.4.2 Russia AI in Pathology Market, By Application
- 9.4.3 Russia AI in Pathology Market, By End User
- 9.4.4 Russia AI in Pathology Market, By Component
- 9.5 Spain AI in Pathology Market
- 9.5.1 Spain AI in Pathology Market, By Neural Network
- 9.5.2 Spain AI in Pathology Market, By Application
- 9.5.3 Spain AI in Pathology Market, By End User
- 9.5.4 Spain AI in Pathology Market, By Component
- 9.6 Italy AI in Pathology Market
- 9.6.1 Italy AI in Pathology Market, By Neural Network
- 9.6.2 Italy AI in Pathology Market, By Application
- 9.6.3 Italy AI in Pathology Market, By End User
- 9.6.4 Italy AI in Pathology Market, By Component
- 9.7 Rest of Europe AI in Pathology Market
- 9.7.1 Rest of Europe AI in Pathology Market, By Neural Network
- 9.7.2 Rest of Europe AI in Pathology Market, By Application
- 9.7.3 Rest of Europe AI in Pathology Market, By End User
- 9.7.4 Rest of Europe AI in Pathology Market, By Component
- Chapter 10. Company Profiles
- 10.1 Koninklijke Philips N.V.
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expense
- 10.1.5 Recent strategies and developments:
- 10.1.5.1 Product Launches and Product Expansions:
- 10.1.6 SWOT Analysis
- 10.2 F. Hoffmann-La Roche Ltd.
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Partnerships, Collaborations, and Agreements:
- 10.2.6 SWOT Analysis
- 10.3 Hologic, Inc.
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expenses
- 10.3.5 Recent strategies and developments:
- 10.3.5.1 Partnerships, Collaborations, and Agreements:
- 10.3.5.2 Product Launches and Product Expansions:
- 10.3.6 SWOT Analysis
- 10.4 Visiopharm A/S
- 10.4.1 Company Overview
- 10.4.2 Recent strategies and developments:
- 10.4.2.1 Partnerships, Collaborations, and Agreements:
- 10.4.3 SWOT Analysis
- 10.5 Paige AI, Inc.
- 10.5.1 Company Overview
- 10.5.2 Recent strategies and developments:
- 10.5.2.1 Partnerships, Collaborations, and Agreements:
- 10.5.2.2 Product Launches and Product Expansions:
- 10.5.3 SWOT Analysis
- 10.6 PathAI, Inc.
- 10.6.1 Company Overview
- 10.6.2 Recent strategies and developments:
- 10.6.2.1 Partnerships, Collaborations, and Agreements:
- 10.6.3 SWOT Analysis
- 10.7 Aiforia Technologies Plc
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Recent strategies and developments:
- 10.7.3.1 Partnerships, Collaborations, and Agreements:
- 10.7.4 SWOT Analysis
- 10.8 Indica Labs, Inc.
- 10.8.1 Company Overview
- 10.8.2 Recent strategies and developments:
- 10.8.2.1 Partnerships, Collaborations, and Agreements:
- 10.8.3 SWOT Analysis
- 10.9 Optrascan, Inc. (Optra Ventures, LLC)
- 10.9.1 Company Overview
- 10.9.2 Recent strategies and developments:
- 10.9.2.1 Partnerships, Collaborations, and Agreements:
- 10.9.2.2 Product Launches and Product Expansions:
- 10.9.3 SWOT Analysis
- 10.10. MindPeak GmbH
- 10.10.1 Company Overview
- 10.10.2 Recent strategies and developments:
- 10.10.2.1 Partnerships, Collaborations, and Agreements:
- 10.10.3 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook